Skip to main content

  • ASBMR E-News Weekly: September 28, 2023 Edition

    ASBMR E-News Weekly: September 28, 2023 Edition

    • Sep 28, 2023

    View this email in your browser
    TABLE OF CONTENTS
    • First-Time Attendee Webinar
    • ASBMR Podcast Nomination
    • Complement-ARIE Listening Session
    • Symposia Programs in Vancouver
    • Thank You to our CAB Members and Exhibitors
    • Industry Expert Sessions in Vancouver
    • Career Opportunities
    • JBMR® and JBMR® Plus
    • Bone Science in the News
    • Events Calendar
    First ASBMR Annual Meeting? Join Us for First-Time Attendee Pre-Meeting Webinar
     
    We have all the tips and tricks to help you make the most out of your experience at the ASBMR 2023 Annual Meeting. From building your itinerary, balancing active engagement vs. conference burnout, places to grab food and coffee to networking.

    Register below for one of our upcoming sessions on Monday, October 2 at 11:00 AM ET or Tuesday, October 3 at 6:30 PM ET! If you have any questions, please contact us at asbmr@asbmr.org.
    ASBMR's podcast series on rare bone diseases has been shortlisted as a finalist for the Signal Listener's Choice Award and we are currently tied for first place in the voting! 
     
    If you have not already done so, please visit the Signal Award site and vote for "figure 1 presents: DDx A podcast about how doctors think"
     
    The Signal awards are the Oscars of podcasting and are managed by the same team behind the Webbys.
     
    We are proud to be able to bring health and wellness topics to the public in such an engaging and accessible way.
     
    If you have not yet listened to the podcast series – download here.
     

    As part of the planning activities for the Complement Animal Research in Experimentation program, the National Institutes of Health (NIH) Common Fund will be hosting three public listening sessions. These listening sessions will bring together key representatives from multiple sectors to gain insight into current opportunities and roadblocks in NAM development unique to their fields.
     
    To learn more about the Complement-ARIE program and register for the listening sessions, visit the NIH website.
    Don’t Miss These Industry-Supported Symposia Programs in Vancouver!

    Please mark your calendars to attend the following Industry-Supported Symposia next month in Vancouver.  All programs provide Continuing Medical Education credits and are planned independently of the ASBMR.
     
    Saturday, October 14th, 6:45 a.m. – 8:30 a.m., West Meeting Room 205 & 206
    A Review of the Latest Hypoparathyroidism and Hyperparathyroidism Treatment Guidelines: Application to Clinical Practice
    Presented by Ascendis Pharma, Amolyt Pharma and Takeda Pharmaceutical
    Organized by Excel Continuing Education
     
    Saturday, October 14th, 6:45 a.m. – 8:30 a.m., West Meeting Room 202 & 203
    Fibrodysplasia Ossificans Progressiva (FOP): Across the Lifespan
    Presented by Ipsen Biopharmaceuticals, Inc.
    Organized by Excel Continuing Education
     
    Saturday, October 14th, 7:00 p.m. – 9:00 p.m., West Meeting Room 202 & 203
    Biosimilars in Osteoporosis: A New Era
    Presented by SANDOZ, a Novartis Division
    Organized by Excel Continuing Education
     
    Sunday, October 15th, 6:45 a.m. – 8:30 a.m., West Meeting Room 202 & 203
    Developing Global Guidelines for Diagnosing and Managing XLH in Pediatric and
    Adult Populations
    Presented by Kyowa Kirin Pharmaceuticals.
    Organized by Excel Continuing Education
     
    Don’t Miss This Non-CME Promotional Event in Vancouver!
     
    Saturday, October 14th, 7:00 a.m. – 8:30 a.m., West Ballroom D
    Current Concepts in Postmenopausal Osteoporosis
    Presented by Amgen, Inc.
    Program Chair: Robert G. Josse, M.D., University of Toronto, Ontario Canada
    Speaker: Michael McClung, M.D., Oregon Osteoporosis Center, Portland Oregon USA
    *This event is held in conjunction with the ASBMR 2023 Annual Meeting and is not part of the official program.  Amgen, Inc. is wholly responsible for the organization and content for this event.
    ASBMR Thanks Companies, CAB Members and Exhibitors for their 2023 Support!

    The ASBMR gratefully acknowledges the following companies, ASBMR Corporate Advisory Board (CAB) members and exhibitors for their loyalty and commitment to the Society and supporting the bone, mineral and musculoskeletal field (List as of September 27, 2023).
     
    SILVER LEVELSUPPORTERS
    Alexion, AstraZeneca Rare Disease
    Amgen, Inc.
    Ipsen Biopharmaceuticals, Inc.
    Kyowa Kirin
    Sandoz, a Novartis Division
     
    BRONZE LEVEL SUPPORTERS
    Ascendis Pharma A/S
    Inozyme Pharma
    UCB
     
    FRIEND LEVEL SUPPORTERS
    Amolyt Pharma.
    BioMarin Pharmaceutical Inc.
    Calcilytix Therapeutics, Inc. (a BridgeBio company)
    Hologic, Inc.
    Radius Health
    Regeneron Pharmaceuticals, Inc.
    Takeda
    Ultragenyx Pharmaceutical Inc.
      
    2023 Corporate Advisory Board Members
    Alexion, AstraZeneca Rare Disease
    Amgen, Inc.
    Ascendis Pharma A/S
    Ipsen Biopharmaceuticals, Inc.
    Kyowa Kirin
    Radius Health
    Regeneron Pharmaceuticals, Inc.
    Sandoz, a Novartis Division
    Takeda
    UCB
    Ultragenyx Pharmaceutical Inc.
     
    2023 Exhibitors
    3D-Shaper Medical S.L., Booth # 516
    Alexion, Astrazeneca Rare Disease, Booth #109
    AMGEN, Inc., Booth #201
    Ascendis Pharma A/S, Booth #117
    Biomomentum, Booth #221
    Bioseb Instruments, Booth #518
    Bone Health Technologies, Booth #119
    Bruker BioSpin, Booth #420
    Endocrine Society, Booth #520
    HypoPARAthyroidism Association, Booth #217
    Inozyme Pharma, Booth #418
    Ipsen Biopharmaceuticals, Inc., Booth #301
    KUBTEC Scientific, Booth #504
    Kyowa Kirin, Inc. (Commercial Booth), Booth #417
    Kyowa Kirin, Inc. (Medical Booth), Booth #421
    Medimaps Group, Booth #318
    MILabs b.v., Booth #121
    Micro Photonics, Booth #219
    Mindways Software, Inc., Booth #216
    OsteoMetrics, Booth #502
    Pharmatest Services, Booth #218
    Promedius Inc., Booth #416
    QuidelOrtho, Booth #320
    Regeneron Pharmaceuticals, Booth #321
    Research Diets Inc., Booth #319
    Revvity Health Sciences, Inc., Booth #316
    Scanco USA, Inc., Booth #401
    Scintica, Booth #500
    Stratec Medizintechnik GmbH, Booth #317
    Ultragenyx, Booth #403
    XLH Network & Canadian XLH Network, Booth #220
    Attend the Industry Expert Sessions in Vancouver!

    Attend the Industry Expert Sessions taking place in Discovery Hall!  Each will provide an in-depth view on a wide range of topics in the field of rare bone diseases.
     
    Alexion, AstraZeneca Rare Diseases
    Saturday, October 14th, 1:00 p.m. – 1:45 p.m., Discovery Hall
    Investigating Hypophosphatasia
    Presented by: Eric T. Rush, M.D., FAAP, CCD, Clinical Geneticist, , Underdown/Yeomans Endowed Professor Medical Director, Children’s Mercy Hospital and the University of Kansas Medical Center
     
    Ipsen Biopharmaceuticals Inc.
    Saturday, October 14th, 2:00 p.m. – 2:45 p.m., Discovery Hall
    Current and Future Strategies in the Management of Fibrodysplasia Ossificans Progressiva (FOP)
    Presented by: Angela M. Cheung, Ph.D., M.D., FRCPC
     
    Kyowa Kirin
    Sunday, October 15th, 1:00 p.m. – 1:45 p.m., Discovery Hall
    The XLH Experience: Looking Beyond Childhood
    Presented by: Eric T. Rush, M.D., FAAP, CCD, Clinical Geneticist and Susan Starling Hughes, MS, CGC, Senior Genetic Counselor
    Career Opportunities in Bone
    Research Scientist
    The Department of Orthopedic Surgery - UConn Musculoskeletal Institute, Farmington, CT, USA
     
    University Director – Outcomes, Research & Quality
    Department of Orthopedic Surgery and Musculoskeletal Institute - UConn Health, Farmington, CT, USA
     
    Postdoctoral Fellow
    Levi Laboratory – University of Texas Southwestern Medical Center, Dallas, TX, USA
     
    Research Scientist
    Levi Laboratory – University of Texas Southwestern Medical Center, Dallas, TX, USA

    Do you have an open position you are looking to fill? Contact us at asbmr@asbmr.org to have your listing added to e-News Weekly.
    JBMR®
    The latest issue of JBMR® is now available!
           
    Opportunistic screening with CT: comparison of phantomless BMD calibration methods
    Stefan Bartenschlager, Alexander Cavallaro, Tobias Pogarell, Oliver Chaudry, Michael Uder, Sundeep Khosla, Georg Schett, Klaus Engelke
    First Published: 21 September 2023
     
    VEGF Secretion Drives Bone Formation in Classical MAP2K1+ Melorheostosis
    Jules Allbritton-King, Jyotirindra Maity, Amit Patel, Robert A Colbert, Fatemeh Navid, Timothy Bhattacharyya
    First Published: 22 September 2023
     
    Towards improved identification of vertebral fractures in routine CT scans: development and external validation of a machine learning algorithm
    Joeri Nicolaes MSc, Michael Kriegbaum Skjødt MD, Steven Raeymaeckers MD PhD, Christopher Dyer Smith PhD, Bo Abrahamsen MD PhD, Thomas Fuerst PhD, Marc Debois MsC, Dirk Vandermeulen PhD, Cesar Libanati MD
    First Published: 25 September 2023
    JBMR® Plus
    Effects of Incretin Therapy on Skeletal Health in Type 2 Diabetes—A Systematic Review
    Rikke Viggers, Nicklas Højgaard-hessellund Rasmussen, Peter Vestergaard
    First Published: 25 September 2023

    Anti-Siglec-15 Antibody Prevents Marked Bone Loss after Acute Spinal Cord Injury-Induced Immobilization in Rats
    Yuanzhen Peng, Solomon Langermann, Priyanka Kothari, Linda Liu, Wei Zhao, Yizhong Hu, Zihao Chen, Mariana Moraes de Lima Perini, Jiliang Li, Jay Cao, X. Edward Guo, Lieping Chen, William A. Bauman, Weiping Qi
    First Published: 27 September 2023
    Bone Science in the News
    Events Calendar
    Twitter
    Facebook
    LinkedIn
    Instagram
    Contact ASBMR
    ASBMR Business Office
    2001 K Street, NW
    Third Floor North
    Washington, DC 20006 USA
    Tel.: +1 (202) 367-1161
    Fax: +1 (202) 367-2161
    Email: asbmr@asbmr.org


    Want to change how you receive these emails?
    You can update your preferences or unsubscribe from this list






    This email was sent to *|EMAIL|*
    why did I get this?    unsubscribe from this list    update subscription preferences
    *|LIST:ADDRESSLINE|*

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Policies and Procedures for more details